Merck KgaA Asks EU to Approve Multiple Sclerosis Pill
2009.07.23. 23:06, veer
July 23 (Bloomberg) -- Merck KGaA asked European regulators to approve its pill for multiple sclerosis, the next step in the German drugmaker’s race against Novartis AG to market the first oral medicine for the debilitating nerve disease.